Permits and Restrictions |
View Permits |
---|---|
Organism | Homo sapiens, human |
Tissue | mammary gland; breast |
Cell Type | Epithelial |
Product Format | frozen |
Morphology | epithelial |
Culture Properties | adherent |
Biosafety Level |
1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
Disease | ductal carcinoma |
Age | 72 years |
Gender | female |
Ethnicity | Caucasian |
Applications | This cell line is a suitable transfection host. |
Storage Conditions | liquid nitrogen vapor phase |
Karyotype | modal number = 78; range = 73 to 80.The cell line is aneuploid human female, with chromosome counts in the hypertriploid range. The X chromosomes are all abnormal. Normal chromosomes N10 and N13 are clearly under-represented, with chromosomes N2, N12, and N17 also tending to be. Chromosome N8 is over-represented with respect to the copy number of other normal chromosomes, and chromosomes N5 and N18 also usually have more copies than most chromosomes. Four marker chromosomes are found: iso(13q), 10q+, del(X)(q22:), del(11)(p11:). |
---|---|
Images | |
Derivation | The BT-549 line was isolated in 1978 by W.G. Coutinho and E.Y. Lasfargues. Source tissue consisted of a papillary, invasive ductal tumor which had metastasized to 3 of 7 regional lymph nodes. |
Clinical Data | 72 years Caucasian female |
Comments | The established population is polymorphic with epithelial like components and multinucleated giant cells. A mucin-like material was secreted into the medium. |
Complete Growth Medium | The base medium for this cell line is ATCC-formulated RPMI-1640 Medium, Catalog No. 30-2001. To make the complete growth medium, add the following components to the base medium: 0.023 IU/ml insulin; fetal bovine serum to a final concentration of 10%. |
---|---|
Subculturing |
Volumes are given for a 75 cm2 flask. Increase or decrease the amount of dissociation medium needed proportionally for culture vessels of other sizes. Corning® T-75 flasks (catalog #430641) are recommended for subculturing this product.
|
Cryopreservation | Freeze medium: Complete growth medium supplemented with 5% (v/v) DMSO Storage temperature: liquid nitrogen vapor phase |
Culture Conditions | Atmosphere: air, 95%; carbon dioxide (CO2), 5% Temperature: 37°C |
STR Profile | Amelogenin : X CSF1PO: 10 , 12 D13S317: 11 D16S539 : 8 D5S818: 11 D7S820: 9, 10 TPOX: 8 THO1: 9.3 vWA : 15 |
---|---|
Isoenzymes | AK-1, 1 ES-D, 1 G6PD, B GLO-I, 1-2 Me-2, 1 PGM1, 2 PGM3, 1 |
Name of Depositor | W Coutinho, EY Lasfargues |
---|---|
Year of Origin | 1978 |
References |
Katayose Y, et al. Promoting apoptosis: a novel activity associated with the Cyclin-dependent kinase inhibitor p27. Cancer Res. 57: 5441-5445, 1997. PubMed: 9407946 Littlewood-Evans AJ, et al. The osteoclast-associated protease cathepsin K is expressed in human breast carcinoma. Cancer Res. 57: 5386-5390, 1997. PubMed: 9393764 |
Permits |
These permits may be required for shipping this product to Australia:
|
---|---|
Basic Documentation | Product Sheet Certificate of Analysis SDS |
Other Documentation | Cell Micrograph Cancer Cell Line Mutation Data p53 Hotspot Mutation Data |
References |
Katayose Y, et al. Promoting apoptosis: a novel activity associated with the Cyclin-dependent kinase inhibitor p27. Cancer Res. 57: 5441-5445, 1997. PubMed: 9407946 Littlewood-Evans AJ, et al. The osteoclast-associated protease cathepsin K is expressed in human breast carcinoma. Cancer Res. 57: 5386-5390, 1997. PubMed: 9393764 |